ACLARIS THERAPEUTICS INC. - COMMON STOCK

Aclaris Therapeutics Appoints Robert Doody as Vice President, Investor Relations

27 سبتمبر 2022 06:00:24 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

30 أغسطس 2022 06:00:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

03 أغسطس 2022 06:00:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Expands Leadership Team

27 يونيو 2022 06:00:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference

01 يونيو 2022 15:01:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

16 مايو 2022 06:00:01 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update

10 مايو 2022 06:00:02 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium

03 مايو 2022 06:00:01 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update

24 فبراير 2022 06:00:02 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the SVB Leerink Virtual 11th Annual Global Healthcare Conference

02 فبراير 2022 06:00:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Expands Leadership Team

01 فبراير 2022 15:01:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Provides R&D Update

11 يناير 2022 15:01:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual Conference

27 ديسمبر 2021 06:00:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Publication of Preclinical Research of Zunsemetinib in Pancreatic Cancer in Science Translational Medicine

03 ديسمبر 2021 06:00:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Host Virtual R&D Day on December 7, 2021

18 نوفمبر 2021 15:01:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in Upcoming Investor Conferences

03 نوفمبر 2021 06:00:01 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate Update

02 نوفمبر 2021 06:00:02 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Proposed Settlement and Settlement Hearing of Stockholder Derivative Action

27 أغسطس 2021 15:01:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in Upcoming Investor Conferences

26 أغسطس 2021 15:01:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Reports Second Quarter 2021 Financial Results and Provides a Corporate Update

05 أغسطس 2021 06:00:02 بحسب Nasdaq GlobeNewswire